Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MEGF9 anticorps (C-Term)

L’anticorps Lapin Polyclonal anti-MEGF9 a été validé pour WB et IHC (p). Il convient pour détecter MEGF9 dans des échantillons de Humain.
N° du produit ABIN657281

Aperçu rapide pour MEGF9 anticorps (C-Term) (ABIN657281)

Antigène

MEGF9 (Multiple EGF-Like-Domains 9 (MEGF9))

Reactivité

  • 27
  • 11
  • 4
  • 1
Humain

Hôte

  • 26
  • 1
Lapin

Clonalité

  • 27
Polyclonal

Conjugué

  • 11
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp MEGF9 est non-conjugé

Application

  • 16
  • 16
  • 11
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone

RB33557
  • Épitope

    • 7
    • 5
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 521-549, C-Term

    Homologie

    M

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogène

    This MEGF9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 521-549 amino acids from the C-terminal region of human MEGF9.

    Isotype

    Ig Fraction
  • Indications d'application

    WB: 1:1000. IHC-P: 1:10~50

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Date de péremption

    6 months
  • Antigène

    MEGF9 (Multiple EGF-Like-Domains 9 (MEGF9))

    Autre désignation

    MEGF9

    Sujet

    MEGF9 (multiple EGF-like-domains 9) is a novel transmembrane protein with multiple EGF-like repeats, which is predominantly expressed in the developing and adult CNS (central nervous system) and PNS (peripheral nervous system). The domain structure of MEGF9 consists of an N-terminal region with several potential O-glycosylation sites followed by five EGF-like domains, which are highly homologous with the short arms of laminins. Following one single pass transmembrane domain, a highly conserved short intracellular domain with potential phosphorylation sites is present.

    Poids moléculaire

    62984

    NCBI Accession

    NP_001073966

    UniProt

    Q9H1U4
Vous êtes ici:
Chat with us!